Meyer Andrew Hollman - Insider Non-Derivative Transactions at Janux Therapeutics, Inc. (JANX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 27, 2024, Meyer Andrew Hollman's relationship to Janux Therapeutics, Inc. (JANX) is Officer (Chief Business Officer), and currently has 117,592 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other JANX insiders.
Data Source: SEC.
Meyer Andrew Hollman - Insider Non-Derivative Transactions at JANX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 28, 2024 | Sell -- (Common Stock) | 50000 | 45.96 | 67592 |
| Sep 28, 2024 | M -- (Common Stock) | 50000 | 4.21 | 117592 |